Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells

Erlotinib in Previously Treated Non–Small-Cell Lung Cancer

Frances A. Shepherd, José Rodrigues Pereira, Tudor–Eliade Ciuleanu et al. · New England Journal of Medicine · 2005 · 5.5K citations · Full text

Medicine, Oncology, Pharmacology +15

Cancer statistics, 1999

Sarah Landis, Thomas S. Murray, S. Bolden et al. · CA A Cancer Journal for Clinicians · 1999 · 3.1K citations · Full text

Medicine, Biostatistics, Oncology +17

Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis.

Michele Relf, S LeJeune, Prudence A. E. Scott et al. · PubMed · 1997 · 834 citations

Medicine, Cancer Biology, Oncology +12

Association of hypoxia‐inducible factors 1α and 2α with activated angiogenic pathways and prognosis in patients with endometrial carcinoma

Efthimios Sivridis, Alexandra Giatromanolaki, Kevin C. Gatter et al. · Cancer · 2002 · 218 citations · Full text

Medicine, Cancer Biology, Oncology +15

Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers.

T.S. O'Brien, Stephen B. Fox, Andrew J. Dickinson et al. · PubMed · 1996 · 149 citations

Medicine, Cancer Biology, Oncology +13